Bonum Therapeutics
Seattle
About Bonum Therapeutics
Bonum Therapeutics is creating a technology platform that can be used to treat a wide range of diseases, including cancer which is the company’s primary therapeutic area of focus’as well as metabolic diseases, immunology, and pain management.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $93.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2022)
- Website: bonumtx.com
- Phone: 206.888.8485
Industries & Categories
Biotechnology, Life Science, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/bonum-therapeutics-56959 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.